Concepedia

J. Larkin

JL

Statistics

Publications

1

Citations

15

H-Index

1

Active since

2019

Affiliations

Cambridge University Hospitals NHS Foundation Trust(Current)

J. Larkin is an author at Cambridge University Hospitals NHS Foundation Trust specializing in cancer pharmacology, medical oncology, and oncology.

Publications per year

2019–2019

1

Publications

1

SELPAC: A 3 arm randomised phase II study of the MEK inhibitor selumetinib alone or in combination with paclitaxel (PT) in metastatic uveal melanoma (UM)

Paul Nathan, A. Needham, P. Corrie et al. · Annals of Oncology · 2019 · 15 citations · Full text

, , +14

1–1 of 1